Is a complete MGNX research report available?

No complete published report is available for MacroGenics, Inc. (MGNX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

MacroGenics, Inc. (MGNX)

NASDAQ: MGNX · USD

$3.78

+0.11 (+3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MGNX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	240.3M
Revenue (ttm)	157.1M
Net income (ttm)	-70.4M
EPS (ttm)	-$1.11
Shares out	63.6M
Volume	274,225
Beta	1.18
Price target	$6.75	+78.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 157.1M
Net income (ttm): -70.4M
EPS (ttm): -$1.11
Market cap: 240.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MGNX indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001125345
Company name	MacroGenics, Inc.
Country	United States
Country code	US
Cusip	556099109
Employees	293
Employees Change	-48%
Employees Change Percent	-14.08
Enterprise value	$122.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-10-10
Isin	US5560991094
Last refreshed	2026-07-31
Market cap	$240.3M
Market cap category	Micro-Cap
Price	$3.78
Price currency	USD
Rev Per Employee	536,119.45x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	MGNX
Website	https://www.macrogenics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.28%
EV Sales Forward	1.02x
EV/Sales	0.78x
FCF yield	-29.84%
P/B ratio	11.33x
P/S ratio	1.53x
PS Forward	2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-40.53%
EBITDA Margin	-36.01%
Gross margin	-16.24%
Gross Profit	$-25.5M
Net Income	$-70.4M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-45.22%
Profit Margin	-44.79%
Profit Per Employee	$-240,130
ROA	-17.98
Roa5y	-27.74
ROCE	-52.21
ROE	-140.3
Roe5y	-56.24
ROIC	-45.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.87%
Cagr1y	139.38%
Cagr3y	-6.8%
Cagr5y	-32.05%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	1.97x
Revenue Growth Q	57.48x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.69x
Revenue Growth5 Y	7.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.71
Assets	$217.9M
Cash	$154.2M
Current Assets	$182.5M
Current Liabilities	$95.9M
Debt	$36.5M
Debt Equity	$1.72
Equity	$21.2M
Interest Coverage	-4.78
Liabilities	$196.7M
Long Term Assets	$35.4M
Long Term Liabilities	$100.7M
Net Cash	$117.7M
Net Cash By Market Cap	$49
Net Cash Growth	0.9%
Net Debt Equity	$-5.55
Tangible Book Value	$21.2M
Tangible Book Value Per Share	$0.33
WACC	13.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	19.3
Net Working Capital	$-62.4M
Quick ratio	1.72
Working Capital	$86.6M
Working Capital Turnover	$1.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.77%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.64%
1Y total return	139.24%
200-day SMA	2.71
3Y total return	-19.06%
50-day SMA	4.29
50-day SMA vs 200-day SMA	50over200
5Y total return	-85.51%
All Time High	41
All Time High Change	-90.78%
All Time High Date	2014-02-03
All Time Low	0.99
All Time Low Change	281.93%
All Time Low Date	2025-04-07
ATR	0.33
Beta	1.18
Beta1y	0.2
Beta2y	1.96
Ch YTD	134.8
High	3.82
High52	5.08
High52 Date	2026-06-24
High52ch	-25.59%
Low	3.66
Low52	1.29
Low52 Date	2025-11-07
Low52ch	193.02%
Ma50ch	-11.83%
Premarket Change Percent	-0.27
Premarket Price	$3.66
Premarket Volume	170
Price vs 200-day SMA	39.64%
RSI	41.67
RSI Monthly	50.23
RSI Weekly	55.6
Sharpe ratio	1.34x
Sortino ratio	2.85
Total Return	-0.77%
Tr YTD	134.8
Tr1m	-22.22%
Tr1w	-5.74%
Tr3m	28.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	5
Analyst Price Target Top	$6.33
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.14
Earnings Revenue Estimate	56,117,736x
Earnings Revenue Estimate Growth	152.32x
Operating Income	$-63.7M
Operating margin	-40.52
Price target	$6.75
Price Target Change	$78.57
Price Target Change Top	$67.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,877,248%
Float Percent	87.91%
Shares Insiders	2.63%
Shares Institutions	60.09%
Shares Out	63,563,123
Shares Qo Q	0.26%
Shares Yo Y	0.77%
Short Float	10.18%
Short Ratio	4.17
Short Shares	8.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-84.2M
Adjusted OCF	-82,507,000
Average Volume	844,847.85x
Bv Per Share	0.33
CAPEX	$-1.7M
Ch10y	-87.64
Ch1m	-22.22
Ch1w	-5.74
Ch1y	139.2
Ch3m	28.57
Ch3y	-19.06
Ch5y	-85.51
Ch6m	95.86
Change	3%
Change From Open	2.72
Close	3.67
Days Gap	0.27
Depreciation Amortization	7,088,000
Dollar Volume	1,036,570.5
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-63.7M
EBITDA	$-56.6M
EPS	$-1.11
F Score	3
FCF	$-71.7M
FCF EV Yield	-58.5x
FCF Per Share	$-1.13
Financing CF	69,589,000
Fiscal Year End	December
Founded	2,000
Income Tax	$-672,000
Investing CF	-78,681,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	3.1
Ma150ch	22.09%
Ma20	4.27
Ma20ch	-11.56%
Net CF	-79,053,000
Next Earnings Date	2026-08-13
Open	3.68
Optionable	Yes
Position In Range	75
Post Close	3.78
Postmarket Change Percent	5.56
Postmarket Price	$3.99
Ppne	33,974,000
Pre Close	3.67
Price Date	2026-07-30
Ptbv Ratio	11.33
Relative Volume	0.32x
Revenue	157,083,000x
SBC By Revenue	7.99x
Share Based Comp	12,546,000
Tax By Revenue	-0.43x
Tr6m	95.86%
Us State	Maryland
Volume	274,225
Z Score	-7.67

MacroGenics, Inc. (MGNX)

Coverage state: Market snapshot only — no published research

Generate the first MGNX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MGNX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MGNX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MGNX

Frequently asked questions